Abbott Laboratories Is the Latest Company to Get Involved in the Weight Loss Market. Here's How.

One of the biggest themes in the healthcare industry right now is the rise of effective new obesity and diabetes medications. Novo Nordisk and Eli Lilly are dominating the space with blockbuster drugs including Ozempic, Rybelsus, Wegovy, Mounjaro, and Zepbound.As demand for these glucagon-like peptide-1 (GLP-1) agonists continues to surge, other pharmaceutical companies, including Hims & Hers Health and start-up Ro, are looking to make inroads with their own versions.But savvy investors understand that othe ...